On February 8, 2019, the Board of Directors of CohBar, Inc. increased the number of its directors to seven and, effective February 11, 2019, appointed Dr. Phyllis Gardner as a member of the Board. Dr. Gardner was also appointed as a member of the Board's Audit Committee, effective February 11, 2019. Dr. Gardner has over 35 years of experience in medicine, the medical industry and academia. Dr. Gardner has served as a director of Revance Therapeutics, Inc. from November 2007 to November 2018.